Association of early acetaminophen administration with mortality in surgical intensive care patients: a retrospective cohort study
Acetaminophen, a widely used analgesic, has drawn attention for its potential to reduce oxidative stress through inhibiting lipid peroxidation and scavenging free radicals. Emerging evidence indicates that early acetaminophen administration might improve survival outcomes in surgical intensive care...
Saved in:
| Published in: | Frontiers in pharmacology Vol. 16; p. 1588978 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Switzerland
Frontiers Media S.A
2025
|
| Subjects: | |
| ISSN: | 1663-9812, 1663-9812 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Acetaminophen, a widely used analgesic, has drawn attention for its potential to reduce oxidative stress through inhibiting lipid peroxidation and scavenging free radicals. Emerging evidence indicates that early acetaminophen administration might improve survival outcomes in surgical intensive care unit (SICU) patients. This study aims to explore the relationship between early acetaminophen use and mortality in this patient population.
We conducted a retrospective cohort analysis of adult SICU patients using the Medical Information Mart for Intensive Care (MIMIC-IV) database, which contains data on patients admitted between 2008 and 2019. The intervention cohort received acetaminophen within 48 h of ICU admission, while controls received no early acetaminophen. The primary endpoint was in-hospital mortality. We implemented 1:1 propensity score matching (PSM) to minimize selection bias and balance baseline characteristics between cohorts. Multivariable Cox regression models adjusted for residual confounding.
From 5,474 eligible patients, we generated balanced cohorts of 2,740 matched pairs. The acetaminophen group demonstrated significantly lower in-hospital mortality (11.4% vs 14.4%; adjusted HR 0.75, 95% CI 0.62-0.89,
= 0.001) compared to controls. This mortality reduction persisted consistently through sensitivity analyses and subgroup evaluations. Notably, early acetaminophen administration associated with improved survival metrics across multiple timepoints: ICU mortality (adjusted HR 0.63, 0.48-0.82;
= 0.001), 90-day mortality (adjusted HR 0.78, 0.66-0.92;
= 0.004), and 180-day mortality (adjusted HR 0.78, 0.67-0.92;
= 0.002). While no significant differences were observed in ICU or hospital length of stay between groups, early acetaminophen administration was linked to longer ICU-free days through day 28 (
= 0.71;
= 0.022) and longer vasopressor-free days through day 28 (
= 0.77;
= 0.012).
Early acetaminophen administration demonstrates independent associations with reduced in-hospital mortality and improved secondary clinical outcomes in surgical ICU populations. These findings highlight the need for prospective trials to confirm therapeutic efficacy and establish causal inference for this readily available pharmacologic intervention. |
|---|---|
| AbstractList | Acetaminophen, a widely used analgesic, has drawn attention for its potential to reduce oxidative stress through inhibiting lipid peroxidation and scavenging free radicals. Emerging evidence indicates that early acetaminophen administration might improve survival outcomes in surgical intensive care unit (SICU) patients. This study aims to explore the relationship between early acetaminophen use and mortality in this patient population.
We conducted a retrospective cohort analysis of adult SICU patients using the Medical Information Mart for Intensive Care (MIMIC-IV) database, which contains data on patients admitted between 2008 and 2019. The intervention cohort received acetaminophen within 48 h of ICU admission, while controls received no early acetaminophen. The primary endpoint was in-hospital mortality. We implemented 1:1 propensity score matching (PSM) to minimize selection bias and balance baseline characteristics between cohorts. Multivariable Cox regression models adjusted for residual confounding.
From 5,474 eligible patients, we generated balanced cohorts of 2,740 matched pairs. The acetaminophen group demonstrated significantly lower in-hospital mortality (11.4% vs 14.4%; adjusted HR 0.75, 95% CI 0.62-0.89,
= 0.001) compared to controls. This mortality reduction persisted consistently through sensitivity analyses and subgroup evaluations. Notably, early acetaminophen administration associated with improved survival metrics across multiple timepoints: ICU mortality (adjusted HR 0.63, 0.48-0.82;
= 0.001), 90-day mortality (adjusted HR 0.78, 0.66-0.92;
= 0.004), and 180-day mortality (adjusted HR 0.78, 0.67-0.92;
= 0.002). While no significant differences were observed in ICU or hospital length of stay between groups, early acetaminophen administration was linked to longer ICU-free days through day 28 (
= 0.71;
= 0.022) and longer vasopressor-free days through day 28 (
= 0.77;
= 0.012).
Early acetaminophen administration demonstrates independent associations with reduced in-hospital mortality and improved secondary clinical outcomes in surgical ICU populations. These findings highlight the need for prospective trials to confirm therapeutic efficacy and establish causal inference for this readily available pharmacologic intervention. BackgroundAcetaminophen, a widely used analgesic, has drawn attention for its potential to reduce oxidative stress through inhibiting lipid peroxidation and scavenging free radicals. Emerging evidence indicates that early acetaminophen administration might improve survival outcomes in surgical intensive care unit (SICU) patients. This study aims to explore the relationship between early acetaminophen use and mortality in this patient population.MethodsWe conducted a retrospective cohort analysis of adult SICU patients using the Medical Information Mart for Intensive Care (MIMIC-IV) database, which contains data on patients admitted between 2008 and 2019. The intervention cohort received acetaminophen within 48 h of ICU admission, while controls received no early acetaminophen. The primary endpoint was in-hospital mortality. We implemented 1:1 propensity score matching (PSM) to minimize selection bias and balance baseline characteristics between cohorts. Multivariable Cox regression models adjusted for residual confounding.ResultsFrom 5,474 eligible patients, we generated balanced cohorts of 2,740 matched pairs. The acetaminophen group demonstrated significantly lower in-hospital mortality (11.4% vs 14.4%; adjusted HR 0.75, 95% CI 0.62–0.89, P = 0.001) compared to controls. This mortality reduction persisted consistently through sensitivity analyses and subgroup evaluations. Notably, early acetaminophen administration associated with improved survival metrics across multiple timepoints: ICU mortality (adjusted HR 0.63, 0.48–0.82; P = 0.001), 90-day mortality (adjusted HR 0.78, 0.66–0.92; P = 0.004), and 180-day mortality (adjusted HR 0.78, 0.67–0.92; P = 0.002). While no significant differences were observed in ICU or hospital length of stay between groups, early acetaminophen administration was linked to longer ICU-free days through day 28 (β = 0.71; P = 0.022) and longer vasopressor-free days through day 28 (β = 0.77; P = 0.012).ConclusionEarly acetaminophen administration demonstrates independent associations with reduced in-hospital mortality and improved secondary clinical outcomes in surgical ICU populations. These findings highlight the need for prospective trials to confirm therapeutic efficacy and establish causal inference for this readily available pharmacologic intervention. Acetaminophen, a widely used analgesic, has drawn attention for its potential to reduce oxidative stress through inhibiting lipid peroxidation and scavenging free radicals. Emerging evidence indicates that early acetaminophen administration might improve survival outcomes in surgical intensive care unit (SICU) patients. This study aims to explore the relationship between early acetaminophen use and mortality in this patient population.BackgroundAcetaminophen, a widely used analgesic, has drawn attention for its potential to reduce oxidative stress through inhibiting lipid peroxidation and scavenging free radicals. Emerging evidence indicates that early acetaminophen administration might improve survival outcomes in surgical intensive care unit (SICU) patients. This study aims to explore the relationship between early acetaminophen use and mortality in this patient population.We conducted a retrospective cohort analysis of adult SICU patients using the Medical Information Mart for Intensive Care (MIMIC-IV) database, which contains data on patients admitted between 2008 and 2019. The intervention cohort received acetaminophen within 48 h of ICU admission, while controls received no early acetaminophen. The primary endpoint was in-hospital mortality. We implemented 1:1 propensity score matching (PSM) to minimize selection bias and balance baseline characteristics between cohorts. Multivariable Cox regression models adjusted for residual confounding.MethodsWe conducted a retrospective cohort analysis of adult SICU patients using the Medical Information Mart for Intensive Care (MIMIC-IV) database, which contains data on patients admitted between 2008 and 2019. The intervention cohort received acetaminophen within 48 h of ICU admission, while controls received no early acetaminophen. The primary endpoint was in-hospital mortality. We implemented 1:1 propensity score matching (PSM) to minimize selection bias and balance baseline characteristics between cohorts. Multivariable Cox regression models adjusted for residual confounding.From 5,474 eligible patients, we generated balanced cohorts of 2,740 matched pairs. The acetaminophen group demonstrated significantly lower in-hospital mortality (11.4% vs 14.4%; adjusted HR 0.75, 95% CI 0.62-0.89, P = 0.001) compared to controls. This mortality reduction persisted consistently through sensitivity analyses and subgroup evaluations. Notably, early acetaminophen administration associated with improved survival metrics across multiple timepoints: ICU mortality (adjusted HR 0.63, 0.48-0.82; P = 0.001), 90-day mortality (adjusted HR 0.78, 0.66-0.92; P = 0.004), and 180-day mortality (adjusted HR 0.78, 0.67-0.92; P = 0.002). While no significant differences were observed in ICU or hospital length of stay between groups, early acetaminophen administration was linked to longer ICU-free days through day 28 (β = 0.71; P = 0.022) and longer vasopressor-free days through day 28 (β = 0.77; P = 0.012).ResultsFrom 5,474 eligible patients, we generated balanced cohorts of 2,740 matched pairs. The acetaminophen group demonstrated significantly lower in-hospital mortality (11.4% vs 14.4%; adjusted HR 0.75, 95% CI 0.62-0.89, P = 0.001) compared to controls. This mortality reduction persisted consistently through sensitivity analyses and subgroup evaluations. Notably, early acetaminophen administration associated with improved survival metrics across multiple timepoints: ICU mortality (adjusted HR 0.63, 0.48-0.82; P = 0.001), 90-day mortality (adjusted HR 0.78, 0.66-0.92; P = 0.004), and 180-day mortality (adjusted HR 0.78, 0.67-0.92; P = 0.002). While no significant differences were observed in ICU or hospital length of stay between groups, early acetaminophen administration was linked to longer ICU-free days through day 28 (β = 0.71; P = 0.022) and longer vasopressor-free days through day 28 (β = 0.77; P = 0.012).Early acetaminophen administration demonstrates independent associations with reduced in-hospital mortality and improved secondary clinical outcomes in surgical ICU populations. These findings highlight the need for prospective trials to confirm therapeutic efficacy and establish causal inference for this readily available pharmacologic intervention.ConclusionEarly acetaminophen administration demonstrates independent associations with reduced in-hospital mortality and improved secondary clinical outcomes in surgical ICU populations. These findings highlight the need for prospective trials to confirm therapeutic efficacy and establish causal inference for this readily available pharmacologic intervention. |
| Author | Shi, Yongyong Chen, Hanli Li, Yihao Li, Jiajing Zhong, Min Wang, Ziyang Wu, Jianwei |
| Author_xml | – sequence: 1 givenname: Jiajing surname: Li fullname: Li, Jiajing – sequence: 2 givenname: Yihao surname: Li fullname: Li, Yihao – sequence: 3 givenname: Min surname: Zhong fullname: Zhong, Min – sequence: 4 givenname: Hanli surname: Chen fullname: Chen, Hanli – sequence: 5 givenname: Ziyang surname: Wang fullname: Wang, Ziyang – sequence: 6 givenname: Jianwei surname: Wu fullname: Wu, Jianwei – sequence: 7 givenname: Yongyong surname: Shi fullname: Shi, Yongyong |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40926990$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkU9v3CAQxVGVqkm3-QI9VBx72S0G20BvUdQ_kSL10p7RGIYskW1cwK322k9esruNikbiifnNQ5r3mlzMcUZC3jZsJ4TSH_yyh7TjjHe7plNKS_WCXDV9L7ZaNfziP31JrnN-ZPUIrUXfviKXLdO815pdkT83OUcboIQ40-gpQhoPFCwWmMIclz3OFFyVIZd0on6HsqdTTAXGUA40zDSv6SFYGKsuOOfwC6mFhHSpAziX_JECTVhSzAvacmzHfTWguazu8Ia89DBmvD7fG_Lj86fvt1-399--3N3e3G-t6PuyRe5d33WN7JkSgrlGaQ-DdLLDRlnHnJdu4NpazYVHbLXUWjJkHe-9EhbFhtydfF2ER7OkMEE6mAjBHB9iejCQSrAjGgm2dYii6bhsrWTgrR3swOwAHdd1sRvy_uS1pPhzxVzMFLLFcYQZ45qN4K1qa3Wiou_O6DpM6J4__pdBBfgJsHVBOaF_RhpmnrI2x6zNU9bmnLX4C4wQoMk |
| Cites_doi | 10.1186/s12933-024-02293-0 10.21037/atm.2016.08.57 10.1016/j.jlr.2021.100024 10.1001/jama.2019.11825 10.1073/pnas.0910174107 10.1097/CCM.0b013e3182741a54 10.1080/17425255.2020.1817896 10.1016/j.compbiomed.2019.103339 10.1002/emp2.12479 10.1186/s13054-015-0865-1 10.1186/s12974-016-0781-6 10.3390/cells13231951 10.3389/fmed.2024.1346855 10.1016/j.jchromb.2012.12.009 10.1016/j.jtcvs.2022.09.005 10.1097/CCM.0000000000000718 10.1371/journal.pmed.0040296 10.13026/6MM1-EK67 10.1016/j.jcrc.2020.10.016 10.1001/jamasurg.2024.2906 10.1136/bmj-2021-069620 10.3389/fmed.2022.1085932 10.1053/j.ajkd.2022.11.009 10.3389/fphar.2024.1445975 10.1111/anae.13562 10.1016/j.fct.2013.03.026 |
| ContentType | Journal Article |
| Copyright | Copyright © 2025 Li, Li, Zhong, Chen, Wang, Wu and Shi. |
| Copyright_xml | – notice: Copyright © 2025 Li, Li, Zhong, Chen, Wang, Wu and Shi. |
| DBID | AAYXX CITATION NPM 7X8 DOA |
| DOI | 10.3389/fphar.2025.1588978 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1663-9812 |
| ExternalDocumentID | oai_doaj_org_article_7ac4dee315274c70afccbcb0cba52966 40926990 10_3389_fphar_2025_1588978 |
| Genre | Journal Article |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M~E O5R O5S OK1 P2P PGMZT RNS RPM IPNFZ M48 NPM RIG 7X8 |
| ID | FETCH-LOGICAL-c366t-e2fd65517608330d189fab7d75e18cd0df7db29cc923fee4979970e0526f83ce3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001565396700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1663-9812 |
| IngestDate | Fri Oct 03 12:52:25 EDT 2025 Wed Sep 10 23:55:36 EDT 2025 Sat Sep 13 02:30:28 EDT 2025 Sat Nov 29 07:39:26 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | mortality acetaminophen critical illness oxidative stress surgical intensive care unit |
| Language | English |
| License | Copyright © 2025 Li, Li, Zhong, Chen, Wang, Wu and Shi. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c366t-e2fd65517608330d189fab7d75e18cd0df7db29cc923fee4979970e0526f83ce3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/7ac4dee315274c70afccbcb0cba52966 |
| PMID | 40926990 |
| PQID | 3248448453 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_7ac4dee315274c70afccbcb0cba52966 proquest_miscellaneous_3248448453 pubmed_primary_40926990 crossref_primary_10_3389_fphar_2025_1588978 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-00-00 |
| PublicationDateYYYYMMDD | 2025-01-01 |
| PublicationDate_xml | – year: 2025 text: 2025-00-00 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in pharmacology |
| PublicationTitleAlternate | Front Pharmacol |
| PublicationYear | 2025 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Zhao (B25) 2017; 14 Endeshaw (B4) 2023; 9 Xiong (B21) 2023; 81 Janz (B8) 2013; 41 Liu (B13) 2024; 23 Sakkat (B16) 2021; 61 Boutaud (B2) 2010; 107 Janz (B9) 2015; 43 Prasain (B15) 2013 Yi (B22) 2024; 15 Smith (B17) 2021; 62 Holgersson (B7) 2022; 378 Zhang (B24) 2017; 5 Cho (B3) 2021; 2 Johnson (B10) 2023 Young (B23) 2024; 167 Zivkovic (B26) 2024; 13 Suzuki (B19) 2015; 19 Kelly (B12) 2016; 71 Fowler (B5) 2019; 322 Sun (B18) 2024; 11 von Elm (B20) 2007; 4 Akakpo (B1) 2020; 16 Karapetsa (B11) 2013; 61 Grafféo (B6) 2019; 111 Lopez (B14) 2024; 159 |
| References_xml | – volume: 23 start-page: 193 year: 2024 ident: B13 article-title: Association of the TyG index with prognosis in surgical intensive care patients: data from the MIMIC-IV publication-title: Cardiovasc Diabetol. doi: 10.1186/s12933-024-02293-0 – volume: 5 start-page: 7 year: 2017 ident: B24 article-title: Propensity score method: a non-parametric technique to reduce model dependence publication-title: Ann. Transl. Med. doi: 10.21037/atm.2016.08.57 – volume: 62 start-page: 100024 year: 2021 ident: B17 article-title: Perioperative high density lipoproteins, oxidative stress, and kidney injury after cardiac surgery publication-title: J. Lipid Res. doi: 10.1016/j.jlr.2021.100024 – volume: 322 start-page: 1261 year: 2019 ident: B5 article-title: Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2019.11825 – volume: 107 start-page: 2699 year: 2010 ident: B2 article-title: Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0910174107 – volume: 41 start-page: 784 year: 2013 ident: B8 article-title: Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study publication-title: Crit. Care Med. doi: 10.1097/CCM.0b013e3182741a54 – volume: 16 start-page: 1039 year: 2020 ident: B1 article-title: Novel strategies for the treatment of acetaminophen hepatotoxicity publication-title: Expert Opin. Drug Metab. Toxicol. doi: 10.1080/17425255.2020.1817896 – volume: 111 start-page: 103339 year: 2019 ident: B6 article-title: Ipcwswitch: an R package for inverse probability of censoring weighting with an application to switches in clinical trials publication-title: Comput. Biol. Med. doi: 10.1016/j.compbiomed.2019.103339 – volume: 2 start-page: e12479 year: 2021 ident: B3 article-title: ICU-Free days as a more sensitive primary outcome for clinical trials in critically ill pediatric patients publication-title: J. Am. Coll. Emerg. Physicians Open doi: 10.1002/emp2.12479 – volume: 19 start-page: 162 year: 2015 ident: B19 article-title: Paracetamol therapy and outcome of critically ill patients: a multicenter retrospective observational study publication-title: Crit. Care doi: 10.1186/s13054-015-0865-1 – volume: 14 start-page: 17 year: 2017 ident: B25 article-title: Acetaminophen attenuates lipopolysaccharide-induced cognitive impairment through antioxidant activity publication-title: J. Neuroinflammation doi: 10.1186/s12974-016-0781-6 – volume: 13 start-page: 1951 year: 2024 ident: B26 article-title: Role of oxidative stress and inflammation in postoperative complications and quality of life after laryngeal cancer surgery publication-title: Cells doi: 10.3390/cells13231951 – volume: 11 start-page: 1346855 year: 2024 ident: B18 article-title: Association between acetaminophen administration and clinical outcomes in patients with sepsis admitted to the ICU: a retrospective cohort study publication-title: Front. Med. (Lausanne) doi: 10.3389/fmed.2024.1346855 – start-page: 161 year: 2013 ident: B15 article-title: Simultaneous quantification of F2-isoprostanes and prostaglandins in human urine by liquid chromatography tandem-mass spectrometry publication-title: J. Chromatogr. B doi: 10.1016/j.jchromb.2012.12.009 – volume: 167 start-page: 1372 year: 2024 ident: B23 article-title: Perioperative acetaminophen is associated with reduced acute kidney injury after cardiac surgery publication-title: J. Thorac. Cardiovasc. Surg. doi: 10.1016/j.jtcvs.2022.09.005 – volume: 43 start-page: 534 year: 2015 ident: B9 article-title: Randomized, placebo-controlled trial of acetaminophen for the reduction of oxidative injury in severe sepsis: the acetaminophen for the reduction of oxidative injury in severe sepsis trial publication-title: Crit. Care Med. doi: 10.1097/CCM.0000000000000718 – volume: 4 start-page: e296 year: 2007 ident: B20 article-title: The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies publication-title: PLoS Med. doi: 10.1371/journal.pmed.0040296 – year: 2023 ident: B10 article-title: MIMIC-IV publication-title: Physio. Net doi: 10.13026/6MM1-EK67 – volume: 61 start-page: 89 year: 2021 ident: B16 article-title: Temperature control in critically ill patients with fever: a meta-analysis of randomized controlled trials publication-title: J. Crit. Care doi: 10.1016/j.jcrc.2020.10.016 – volume: 159 start-page: 1106 year: 2024 ident: B14 article-title: Intraoperative oxygen treatment, oxidative stress, and organ injury following cardiac surgery: a randomized clinical trial publication-title: JAMA Surg. doi: 10.1001/jamasurg.2024.2906 – volume: 378 start-page: e069620 year: 2022 ident: B7 article-title: Fever therapy in febrile adults: systematic review with meta-analyses and trial sequential analyses publication-title: BMJ doi: 10.1136/bmj-2021-069620 – volume: 9 start-page: 1085932 year: 2023 ident: B4 article-title: Survival status and predictors of mortality among patients admitted to surgical intensive care units of addis ababa governmental hospitals, Ethiopia: a multicenter retrospective cohort study publication-title: Front. Med. doi: 10.3389/fmed.2022.1085932 – volume: 81 start-page: 675 year: 2023 ident: B21 article-title: Early postoperative acetaminophen administration and severe acute kidney injury after cardiac surgery publication-title: Am. J. Kidney Dis. doi: 10.1053/j.ajkd.2022.11.009 – volume: 15 start-page: 1445975 year: 2024 ident: B22 article-title: Association between acetaminophen administration and outcomes in critically ill patients with gout and hypertension publication-title: Front. Pharmacol. doi: 10.3389/fphar.2024.1445975 – volume: 71 start-page: 1153 year: 2016 ident: B12 article-title: Haemodynamic effects of parenteral vs. enteral paracetamol in critically ill patients: a randomised controlled trial publication-title: Anaesthesia doi: 10.1111/anae.13562 – volume: 61 start-page: 106 year: 2013 ident: B11 article-title: Oxidative status in ICU patients with septic shock publication-title: Food Chem. Toxicol. doi: 10.1016/j.fct.2013.03.026 |
| SSID | ssj0000399364 |
| Score | 2.3688312 |
| Snippet | Acetaminophen, a widely used analgesic, has drawn attention for its potential to reduce oxidative stress through inhibiting lipid peroxidation and scavenging... BackgroundAcetaminophen, a widely used analgesic, has drawn attention for its potential to reduce oxidative stress through inhibiting lipid peroxidation and... |
| SourceID | doaj proquest pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database |
| StartPage | 1588978 |
| SubjectTerms | acetaminophen critical illness mortality oxidative stress surgical intensive care unit |
| Title | Association of early acetaminophen administration with mortality in surgical intensive care patients: a retrospective cohort study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40926990 https://www.proquest.com/docview/3248448453 https://doaj.org/article/7ac4dee315274c70afccbcb0cba52966 |
| Volume | 16 |
| WOSCitedRecordID | wos001565396700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1663-9812 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000399364 issn: 1663-9812 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1663-9812 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000399364 issn: 1663-9812 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07b9RAEF5BREGDCM8jIRoklIaY2F57d00HKBEN0RVBum61T3FFfJHti5QmRX55Zta-5CgQDY0Ly1qv5xvvfLOPbxj7aHzOrcNMtVE2ZpWTLrPexCyq4Bvraww6JhWbkGdnarFo5lulvmhP2CgPPBruWBpX-RA4lV_FpnITnbPO5s4aWjJMYtvIeraSqTQGU9wV1XhKBrOw5jhe_jak_1nWn4taqVRXbSsSJcH-v7PMFG1On7NnE02Er2P3dtmj0L5gh_NRZ_r6CM4fjk31R3AI8wcF6uuX7HbL6LCKEEjFGIwLg7lYtqQk0IL5QzUXaD4WLhIXR14Oyxb6dZdGRVhudrkDbRODSYm1_wIGujB0q81hTaBiu90ASbH2Fft1enL-_Uc2FVvIHBdiyEIZvUD6JAWSMp77QjXRWOllHQrlfO6j9LZsnENGGEOoaDlQ5oHkYqLiLvDXbKddteEtA8EL0zQuOs5DlUc0dsAhV6hCWO5Lx2fs08bw-nLU1NCYixBMOsGkCSY9wTRj3wib-ydJDzvdQC_Rk5fof3nJjH3YIKvx_6FFEdOG1brXSCgVpqhVjd16M0J-_yrMfUuB4frd_-jCHntKnzVO3-yznaFbh_fsibsaln13wB7LhTpITozXnzcnd19C_XI |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+early+acetaminophen+administration+with+mortality+in+surgical+intensive+care+patients%3A+a+retrospective+cohort+study&rft.jtitle=Frontiers+in+pharmacology&rft.au=Jiajing+Li&rft.au=Yihao+Li&rft.au=Min+Zhong&rft.au=Hanli+Chen&rft.date=2025&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=16&rft_id=info:doi/10.3389%2Ffphar.2025.1588978&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_7ac4dee315274c70afccbcb0cba52966 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |